NCT06682806
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06682806
Title A Study of PRT3789 in Combination With Pembrolizumab in Patients With Advanced or Metastatic Solid Tumors With a SMARCA4 Mutation
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Prelude Therapeutics
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | ESP

Facility Status City State Zip Country Details
Florida Cancer Specialists West Palm Beach Florida 33401 United States Details
Karmanos Cancer Institute Detroit Michigan 48201 United States Details
John Theurer Cancer Center at Hackensack University Medical Center Hackensack New Jersey 07601 United States Details
SCRI Oncology Partners Nashville Tennessee 37203 United States Details
Tennessee Oncology, PLLC - Greco-Hainsworth Centers for Research Nashville Tennessee 37203 United States Details
The University of Texas MD Anderson Cancer Center Houston Texas 77030 United States Details
IOB - Next Oncology - Hospital Quironsalud Barcelona Barcelona 08023 Spain Details
START Barcelona - HM Nou Delfos Barcelona 08023 Spain Details
Hospital Universitario Fundacion Jimenez Diaz - Servicio de Oncologia Madrid 28040 Spain Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field